PRX 00933
Alternative Names: 876167; ALT 933; BVT-933; GW 876167; PRX00933Latest Information Update: 28 May 2018
At a glance
- Originator Biovitrum
- Developer Altacor; Proximagen
- Class Anorectics; Obesity therapies
- Mechanism of Action Serotonin 2C receptor agonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Discontinued Glaucoma; Obesity
Most Recent Events
- 04 Aug 2015 Altacor has been acquired by Esperante Ventures
- 14 Aug 2012 Proximagen has been acquired by Upsher-Smith
- 05 Mar 2012 No development reported - Phase-II for Obesity in Sweden (PO)